G1 Therapeutics Ratios and Metrics

Market cap in millions IDR. Fiscal year is January - December.

Millions IDR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '25 Aug 12, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	247,123	247,123	36,610	45,763	-	-
Market Cap Growth	689.47%	575.02%	-20.00%	-	-	-
Enterprise Value	254,334	255,640	44,432	54,485	-	-
Last Close Price	189.00	189.00	28.00	35.00	-	-
PE Ratio	-	-	77.70	-	-	-
PS Ratio	18.09	12.93	2.16	6.09	-	-
PB Ratio	7.81	7.41	1.08	1.37	-	-
P/TBV Ratio	7.81	7.41	1.08	1.37	-	-
P/FCF Ratio	115.63	437.16	-	-	-	-
P/OCF Ratio	59.70	96.33	-	-	-	-
EV/Sales Ratio	18.62	13.38	2.62	7.25	-	-
EV/EBITDA Ratio	-	146.81	12.22	-	-	-
EV/EBIT Ratio	-	862.25	22.56	-	-	-
EV/FCF Ratio	119.01	452.23	-	-	-	-
Debt / Equity Ratio	0.23	0.27	0.26	0.29	0.82	0.15
Debt / EBITDA Ratio	13.44	3.94	2.11	21.02	21.71	0.40
Debt / FCF Ratio	3.45	15.64	-	-	-	1.46
Asset Turnover	0.32	0.43	0.38	0.22	0.31	-
Inventory Turnover	0.74	0.89	0.80	0.76	1.62	-
Quick Ratio	0.39	0.31	1.14	0.83	0.29	0.98
Current Ratio	4.56	5.67	6.86	5.42	1.76	2.11
Return on Equity (ROE)	-8.02%	-1.58%	1.40%	-4.85%	4.76%	-
Return on Assets (ROA)	-2.78%	0.41%	2.75%	-0.74%	1.61%	-
Return on Capital (ROIC)	-2.93%	0.44%	2.87%	-0.81%	2.00%	-
Return on Capital Employed (ROCE)	-	0.70%	4.70%	-	1.70%	27.80%
Earnings Yield	-1.07%	-0.21%	1.29%	-2.35%	-	-
FCF Yield	0.86%	0.23%	-2.10%	-51.30%	-	-
Buyback Yield / Dilution	0.13%	-0.00%	-12.58%	-2308.52%	-20.55%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.